Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Feb 5, 2014 · 10-K · 36 days after period end · 0001069530-14-000004
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $35.24M | $2.47M | $2.75M | — |
| Net Income | $33.02M | -$1.80M | -$391.00K | — |
| EPS Diluted | $0.72 | -$0.04 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 5, 2014 · 36 d after period end
